Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants
NCT07512427
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
MASH
Interventions
DRUG:
OPK-88006
DRUG:
Placebo
Sponsor
OPKO Health, Inc.